The checking methods before medication administration: A perspective from a Joint Commission International-accredited academic medical center hospital in China

2016 ◽  
Vol 23 (3) ◽  
pp. 676-678 ◽  
Author(s):  
Xiu-qin Feng ◽  
Ling-ling Zhu ◽  
Quan Zhou
Keyword(s):  
Medical Center ◽  
Academic Medical Center ◽  
Medication Administration ◽  
Joint Commission ◽  
Academic Medical ◽  
Center Hospital ◽  
Joint Commission International ◽  
Medical Center Hospital

scholarly journals Clinical Profile, Predictors of Mortality, and Treatment of Patients after Myocardial Infarction, in an Academic Medical Center Hospital

2002 ◽  
Vol 78 (4) ◽  
pp. 401-405 ◽  
Author(s):  
Leonardo A. M. Zornoff ◽  
Sérgio A. R. Paiva ◽  
Vanessa M. Assalin ◽  
Patrícia M. S. Pola ◽  
Luís E. Becker ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Medical Center ◽  
Academic Medical Center ◽  
Clinical Profile ◽  
Predictors Of Mortality ◽  
Academic Medical ◽  
Center Hospital ◽  
Medical Center Hospital

scholarly journals A Study on Knowledge Towards Brain Death among Residents in Indonesia

2020 ◽  
Vol 56 (2) ◽  
pp. 140
Author(s):  
Asra Al Fauzi ◽  
Christrijogo Sumartono Waloejo ◽  
Abdulloh Machin ◽  
Muhammad Ja'far Shodiq
Keyword(s):  
Brain Death ◽  
Medical Center ◽  
Academic Medical Center ◽  
Cross Sectional Study ◽  
Research Subjects ◽  
Cross Sectional ◽  
Academic Medical ◽  
Center Hospital ◽  
Level 3 ◽  
Level 2

This research was conducted to evaluate the knowledge and diagnosis of brain death among resident in Indonesia. This study used an observational analytic study with a cross-sectional study design using a questionnaire. The research subjects consisted of 132 level 2 (after 2 years of residency) and level 3 (after 4 years of residency) residents, the total sampling for which was taken from the departments of Neurosurgery, Anesthesiology, and Neurology at Dr. Soetomo Academic Medical Center Hospital, Surabaya, Indonesia. Data were taken from November 2018 to January 2019. A total of 132 residents of Neurosurgery, Neurology, and Anesthesiology participated in this study. From the series of studies, residents’ knowledge of the concept of brain death was in the sufficient category (41.7%), residents’ knowledge of the technical diagnosis of brain death was in the good category (40.2%), residents’ knowledge of brain death examination was in the less category (43.2%), and finally, it was found that the resident's knowledge of brain death was in a good category (35.6%). There were also significant differences in knowledge of brain death between Neurosurgery, Neurology, and Anesthesiologist Resident (P <0.001) and knowledge of brain death between level 2 and level 3 residents (P=0.032). In general, the Indonesian resident doctors’ knowledge of brain death is adequate, but knowledge of the clinical examination of brain death is still lacking. Further research must be carried out to promote knowledge of brain death in residents as well as professional doctors/specialists, so that the number of organ transplants, especially in Indonesia, will increase.

Clinical Experience with Ketorolac in Children

1994 ◽  
Vol 28 (9) ◽  
pp. 1009-1013 ◽  
Author(s):  
Marcia L. Buck ◽  
Maria Rudis
Keyword(s):  
Average Length ◽  
Medical Center ◽  
Academic Medical Center ◽  
Large Population ◽  
Subjective Response ◽  
Academic Medical ◽  
Treatment Dose ◽  
Center Hospital ◽  
Length Of Therapy ◽  
Gastrointestinal Ulceration

OBJECTIVE: To describe the use of parenteral ketorolac in a large population of children, focusing on dosing patterns, efficacy, and safety. DESIGN: Observational, prospective study conducted over a four-month period. SETTING: A 122-bed children's medical center located within an academic medical center hospital. PARTICIPANTS: Children receiving ketorolac during their hospitalization. MAIN OUTCOME PARAMETERS: Indications for treatment, dose, dosing interval, use of a loading dose, length of therapy, efficacy (subjective response and use of concomitant therapy), and adverse effects (bleeding, gastrointestinal ulceration or vomiting, and renal dysfunction). RESULTS: Of 112 children evaluated, 110 received ketorolac for analgesia, and 2 were given ketorolac as an antipyretic. The children ranged in age from 6 months to 19 years. Doses of 0.5 mg/kg q6h were used for most children (range 0.17–1.0). The average length of therapy was 3.4 days (range 1–12). The most frequent reason for discontinuing ketorolac therapy was a change to oral therapy. Therapy was discontinued because of a lack of efficacy in only 2 children. Adverse reactions were unusual, with only 2 patients having bleeding potentially associated with ketorolac use. CONCLUSIONS: Ketorolac appears to be a safe and effective therapy for children when given in appropriate doses for a limited duration.

Sign in / Sign up

Export Citation Format

Share Document